| Revenue | DKK -12K | +1% |
| EBITDA | DKK -12K | -1% |
| Net profit | DKK 705K | -22% |
| Total assets | DKK 8,1M | +1% |
| Equity | DKK 5,4M | +15% |
| Employees | — | — |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -32 | -28 | -7 | -9 | -9 | -14 | -12 | -12 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -32 | -28 | -7 | -9 | -9 | -14 | -12 | -12 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -32 | -28 | -7 | -9 | -9 | -14 | -12 | -12 |
| Net financials | -1.386 | 209 | 60 | -192 | 1.114 | 1.668 | 886 | 691 |
| Profit before tax | -1.418 | 181 | 52 | -201 | 1.105 | 1.654 | 874 | 679 |
| Tax | -67 | -77 | -68 | -51 | -41 | -40 | -32 | -26 |
| Net profit | -1.351 | 257 | 121 | -150 | 1.145 | 1.694 | 906 | 705 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 10.132 | 9.161 | 6.897 | 8.378 | 7.451 | 8.519 | 8.051 | 8.097 |
| Equity | -1.301 | -1.044 | -923 | 904 | 2.048 | 3.742 | 4.665 | 5.377 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 11.433 | 10.205 | 7.820 | 7.473 | 5.403 | 4.777 | 3.386 | 2.720 |
| Total debt | 11.433 | 10.205 | 7.820 | 7.473 | 5.403 | 4.777 | 3.386 | 2.720 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PT Management | Management | 2016 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
DANPROTEIN A/S | Company | 100.0% | 100.0% | 2016 |
| Person | Role here | Other companies |
|---|---|---|
| Peter Theiss Holm | Management | 0 companies |